Antiphospholipid (Hughes) syndrome: Beyond pregnancy morbidity and thrombosis

Journal of Autoimmune Diseases

Volumn 6, Issue 1, 2009, Pages

  Mialdea, Maria ^a   Sangle, Shirish R ^a   D'Cruz, David P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ATHEROMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLOOD VESSEL OCCLUSION; BONE DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; HEADACHE; HUMAN; KIDNEY BIOPSY; LIVEDO RETICULARIS; MIGRAINE; NEUROLOGIC DISEASE; POSTOPERATIVE HEMORRHAGE; PREGNANCY DISORDER; REVIEW; SEIZURE; THROMBOCYTOPENIA; VALVULAR HEART DISEASE; VASCULAR DISEASE; VEIN THROMBOSIS;

EID: 67650652032     PISSN: None     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-6-3     Document Type: Review

References (50)

1. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. GR Hughes, BMJ 1983 287 1088 1089 6414579 10.1136/bmj.287.6399.1088
2. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). S Miyakis MD Lockshin T Atsumi DW Branch RL Brey R Cervera RH Derksen PG DE Groot T Koike PL Meroni G Reber Y Shoenfeld A Tincani PG Vlachoyiannopoulos SA Krilis, J Thromb Haemost 2006 4 295 306 10.1111/j.1538-7836.2006.01753.x 16420554
3. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. MA Khamashta R Cervera RA Asherson J Font A Gil DJ Coltart JJ Vázquez C Paré M Ingelmo J Oliver, Lancet 1990 335 1541 1544 10.1016/0140-6736(90)91373-I 1972484
4. Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome. C Christodoulou S Sangle DP D'Cruz, Rheumatology (Oxford) 2007 46 907 10 10.1093/rheumatology/kem040 17403711
5. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. SR Sangle DP D'Cruz W Jan MY Karim MA Khamashta IC Abbs GR Hughes, Ann Rheum Dis 2003 62 999 1002 12972481 10.1136/ard.62.10.999
6. Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid antibodies. SR Sangle W Jan IS Lau AN Bennett GRV Hughes DP D'Cruz, Clin Exp Rheumatol 2006 24 349 16870110 (Pubitemid 44151162)
7. Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. M Wong S Sangle W Jan GR Hughes DP D'Cruz, Rheumatology (Oxford) 2005 44 948 9 10.1093/rheumatology/keh645 15840600
8. Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies. A Sipek-Dolnicar J Hojnik B Bozic A Vizjak B Rozman D Ferluga, Clin Exp Rheumatol 2002 20 335 42 12102469
9. Antiphospholipid syndrome complicated by thrombosis of the superior mesenteric artery, co-existence of smooth muscle hyperplasia. E Kojima K Naito M Iwai Y Hirose K Isobe K Takano, Intern Med 1997 36 528 31 10.2169/ internalmedicine.36.528 9240507
10. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. SR Sangle DP D'Cruz IC Abbs MA Khamashta GR Hughes, Rheumatology (Oxford) 2005 44 372 377 10.1093/rheumatology/keh490 15572388
11. Treatment of mesenteric angina with antiphospholipid (Hughes) syndrome and coeliac artery stenosis. E Rosenthal SR Sangle P Taylor MA Khamashta GR Hughes DP D'Cruz, Ann Rheum Dis 2006 65 1398 9 10.1136/ard.2005.050344 16973790
12. A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome. GI Remondino E Mysler MN Pissano MC Furattini MC Basta JL Presas A Allievi, Lupus 2000 9 65 7 10.1177/096120330000900112 10713649
13. Coronary and valvular syndromes and antiphospholipid antibodies. R Cervera, Thromb Res 2004 114 501 507 10.1016/j.thromres.2004.06.026 15507284
14. Cardiac involvement in the antiphospholipid syndrome. F Tenedios K Erkan MD Lockshin, Lupus 2005 14 691 696 10.1191/0961203305lu2202oa 16218469
15. Cardiac manifestations of antiphospholipid syndrome. SD Kaplan EK Chartash RA Pizzarello RS Furie, Am Heart J 1992 124 1331 1338 10.1016/0002-8703(92)90420-Z 1442504
16. Antiphospholipid antibodies and myocardial infarction. O Vaarala, Lupus 1998 7 S132 134 10.1177/096120339800700229 9814690
17. Antibodies to cardiolipin in young survivors of myocardial infarctions: an association with recurrent cardiovascular events. A Hamsten R Norberg M Bjorkholm U de Faire G Holm, Lancet 1986 18 113 116 10.1016/S0140-6736(86)92258- 0
18. Syndrome X and Hughes syndrome. S Nair MA Khamashta GRV Hughes, Lupus 2002 11 332 10.1191/0961203302lu210xx 12090572
19. Myocardial infarction with normal coronary arteries in a patient with primary antiphospholipid syndrome. Case report and literature review. B Lagana L Baratta L Tubani V Golluscio M Delfino F Rossi Fanelli, Angiology 2001 52 785 788 10.1177/000331970105201109 11716332 (Pubitemid 33131290)
20. Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. JO Davies BJ Hunt, Int J Clin Pract 2007 61 379 384 10.1111/j.1742-1241.2006.01245.x 17313603
21. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI sponsored Women's ischaemia Syndrome Evaluation (WISE) study. BD Johnson LJ Shaw CJ Pepine SE Reis SF Kelsey G Sopko WJ Rogers S Mankad BL Sharaf V Bittner CN Bairey Merz, Eur Heart J 2006 27 1408 1415 10.1093/eurheartj/ehl040 16720691
22. Cardiac syndrome X in women: the role of oestrogen deficiency. JC Kaski, Heart 2006 92 35 39 16614266 10.1136/hrt.2005.070318
23. Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome. S Sangle D D'Cruz, Lupus 2008 17 83 85 10.1177/0961203307086036 18250128
24. Myocardial infarction caused by microvasculopathy in a patient with primary antiphospholipid syndrome. N Kattwinkel AG Villanueva SB Labib HT Aretz JW Walek DL Burns JT Klenz, Ann Int Med 1992 116 974 976 1586106
25. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. G Sanna D D'Cruz MJ Cuadrado, Rheum Dis Clin North Am 2006 32 465 90 10.1016/j.rdc.2006.05.010 16880079
26. Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome. CR Ciubotaru F Esfahani RH Benedict LM Wild AN Baer, J Clin Rheumatol. 2002 8 6 332 339 10.1097/00124743-200212000-00010 17041404 (Pubitemid 35453602)
27. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. MG Tektonidou N Varsou G Kotoulas A Antoniou HM Moutsopolous, Arch Intern Med. 2006 166 20 2278 2284 10.1001/archinte.166.20.2278 17101948
28. Migraine in Hughes syndrome heparin as a therapeutic trial? MJ Cuadrado MA Khamashta D D'Cruz GRV Hughes, QJM. 2001 94 2 114 115 10.1093/qjmed/94.2.114 11181989 (Pubitemid 32175539)
29. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. MG Tektonoidou K Malagari PG Vlachoyiannopoulos DA Kelekis HM Moutsopoulos, Arthritis Rheum 2003 48 732 736 10.1002/art.10835 12632427
30. Avascular necrosis associated with anticardiolipin antibodies. MJ Seleznick LH Silveira LR Espinoza, J Rheumatol 1991 18 1416 1417 1757948
31. Catastrophic antiphospholipid syndrome presenting with multiple thromboses and sites of avascular necrosis. RM Egan RK Munn, J Rheumatol 1994 21 2376 2379 7699646
32. Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. S Sangle DP D'Cruz MA Khamashta GR Hughes, Ann Rheum Dis 2004 63 1241 3 15361379 10.1136/ard.2003.016105
33. Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. S Vasoo S Sangle M Zain D D'Cruz G Hughes, Lupus 2005 14 339 45 10.1191/0961203305lu2146rr 15934432
34. Antiphospholipid (Hughes) syndrome and atheroma. RJ Davies SR Sangle MA Khamashta DP D'Cruz, Lupus 2006 15 55 58 10.1177/0961203306071669
35. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. MS Brown JL Goldstein, A Rev Biochem 1983 52 223 61 10.1146/annurev.bi.52.070183.001255
36. Enhanced macrophage degradation of biologically modified low density lipoprotein. T Henriksen EM Mahoney D Steinburg, Arteriosclerosis 1983 3 149 59 6838433
37. Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. MA Barn MA Khamashta GR Hughes DP D'Cruz, Ann Rheum Dis 2005 64 144 6 15608314 10.1136/ard.2003.016204
38. Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study. C Christodoulou M Zain ML Bertolaccini S Sangle MA Khamashta GR Hughes DP D'Cruz, Ann Rheum Dis 2006 65 683 4 16611867 10.1136/ard.2005. 037911
39. Endothelial Dysfunction and Increased Carotid Intima-Media Thickness in Primary Antiphospholipid Syndrome. M Charakida JP Halcox S Sangle D D'Cruz AE Donald CG Mackworth-Young NJ Klein G Hughes JE Deanfield, Arthritis Rheum 2006 54 2 557 558 10.1002/art.21569 16447232
40. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. G Medina D Casaos LJ Jara O Vera-Lastra M Fuentes L Barile M Salas, Ann Rheum Dis 2003 62 607 10 12810420 10.1136/ard.62.7.607
41. Subclinical atherosclerosis in primary antiphospholipid syndrome. A Margarita J Batuca G Scenna JD Alves L Lopez L Iannaccone E Matsuura PR Ames, Ann N Y Acad Sci 2007 1108 475 80 10.1196/annals.1422.050 17894012
42. Antiphospholipid antibodies and increased bleeding complications following renal biopsy: a single centre study. AI Chaib N Mellilo SR Sangle T Sabharwal F Tungekar IC Abbs, Arthritis Rheum 2007 56 9 S740
43. Antiphospholipid antibody-negative syndrome other phospholipids. RAS Roubey B Roch O Amengual T Atsumi MA Khamashta GRV Hughes, Hughes Syndrome. Antiphospholipid syndrome London: Springer, Khamashta MA, 2000 253 60
44. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. S Carmo-Pereira ML Bertolaccini A Escudero-Conteras MA Khamashta GR Hughes, Ann Rheum Dis 2003 62 540 3 12759291 10.1136/ard.62.6.540
45. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. C Frances S Niang E Laffitte F Pelletier N Costedoat JC Piette, Arthritis Rheum 2005 52 1785 93 10.1002/art.21041 15934071
46. The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study. S Sangle C Christodoulou S Paul GR Hughes DP D'Cruz, Ann Rheum Dis 2008 67 276 7 10.1136/ard.2007.074567 18192306
47. Sneddon Syndrome with or without antiphospholipid antibodies, A comparative study in 46 patients. C Frances T Papo B Wechsler JL Laporte V Biousse JC Piette, Medicine (Baltimore) 1999 78 209 19 10.1097/00005792- 199907000-00001 10424203
48. Cutaneous manifestations of antiphospholipid antibody syndrome. S Weinstein W Piette, Hematol Oncol Clin North Am 2008 22 67 77 10.1016/j.hoc.2007.10.011 18207066
49. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms. YL Kriseman JW Nash S Hsu, J Am Acad Dermatol 2007 112 5 10.1016/j.jaad.2006.11.033 17467850
50. Seronegative antiphospholipid syndrome. GRV Hughes MA Khamashta, Ann Rheum Dis 2003 62 1127 14644846 10.1136/ard.2003.006163